Search results for: 'complex therapies'

Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

This research identifies some the key developments across CAR-T cell therapies and provides insights across technological, IP, and investment landscapes. The study also provides an analysis of the competitive landscape while highlighting the key growth opportunities within the CAR-T cell therapy platform.

The research provides technological advances and insights across non-opioid pharmaceuticals for the management of pain. Key application areas explored in the research include neuropathic pain, migrane, post-surgical pain, cancer pain, chronic pain and migraine. The research encompasses technological advances across Nav1.7 inhibitors, Calcitonin Gen...

This research service provides an understanding of the significance and impact of digital therapeutics on the emerging applications. Digital therapeutics is evidence-based therapeutic intervention for prevention, management, and treatment of a specific disease condition; it has the potential to address needs that traditional treatments and therapie...

As part of Frost & Sullivan’s ongoing research on Cybersecurity, we conducted a deep-dive into the Global DDoS Mitigation market. Distributed Denial of Service (DDoS), among the most common hacker attacks, overwhelms network hosts with invalid requests from 'distributed’ sources, leading to legitimate requests being lost or ignored in the ensuing m...

The treatment of mental health disorders using pharmaceuticals and psychotherapy are plagued with limitations such as therapy-related adverse effects, and inability to provide effective remission. This has driven the use of neuromodulation techniques for managing these conditions. However, these traditional neuromodulation therapies have their shar...

23 Oct 2020  |  Global  |  Market Research

Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026

Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing Standardization will Create New Growth Opportunities

Infographics

×

The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space. While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater reach and a...

28 Jul 2021  |  Global  |  Market Research

Global Pharmaceutical Packaging Materials Growth Opportunities

Future Growth Potential Enhanced by Increasing Development of Complex Biologics

Infographics

×

The pharmaceutical packaging materials market comprises the following segments: plastic, glass, and others, which includes aluminum, rubber, and paper. By end-product type, the market has been divided into oral drugs, drops and sprays, topical medicines and suppositories, and injectables. Packaging plays a pivotal role in the pharmaceutical indus...

23 Apr 2021  |  Global  |  Market Research

Global Workforce IAM—Disruptive Technologies and Unified Access Solutions Enable Robust Security Postures

Enterprises Benefit from Vendor Focus on Reducing IAM Complexity to Enhance User Experience

Infographics

×

Key Issues Addressed

As part of Frost & Sullivan’s ongoing research on cybersecurity, we conducted a deep-dive analysis of the Workforce Identity and Access Management (IAM) market. Frost & Sullivan defines Workforce IAM as a framework that controls and manages employee identities and access as well as policies across IT infrastructures, to protect enterprises from una...